Cited by 171Gut microbiota and healthPolyamine Metabolism and ApplicationsMetabolism and Genetic Disorders

Trimethylamine N‐oxide: breathe new life

Open access
Subramaniam, Saravanan, Fletcher, Craig·2018·British Journal of Pharmacology

Abstract

Association between elevated levels of systemic trimethylamine N-oxide (TMAO) and increased risk for adverse cardiovascular events have been proposed in recent years. Increasing experimental and clinical evidence in the last decade has implicated TMAO as an important contributor to the pathogenesis of cardiovascular diseases. TMAO, the oxygenated product of trimethylamine (TMA), belongs to the class of amine oxides. Most of the TMA derived from the metabolism of choline and L-carnitine by gut bacteria is absorbed into the bloodstream and gets rapidly oxidized to TMAO by the hepatic enzyme, flavin-containing monooxgenase-3. Here, we discussed the biosynthesis of TMAO and clinical studies that have assessed TMAO as a biomarker for various cardiovascular and other diseases such as kidney failure, thrombosis, atherosclerosis, obesity, diabetes and cancer. We also summarized the interaction of TMAO with synthetic and traditional molecules that together affect circulating TMAO levels. LINKED ARTICLES: This article is part of a themed section on Spotlight on Small Molecules in Cardiovascular Diseases. To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v175.8/issuetoc.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/bph.13959

Cites

84 of 84 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • TMAO has been suggested to cause blood brain barrier disruption by reducing expression of tight junction proteins claudin-5 and ZO-1, favouring its access to the brain.

    “TMAO has been suggested to cause blood brain barrier disruption by reducing the expression of tight junction proteins, such as claudin-5 and tight junction protein-1 (ZO-1), favouring its access to the brain [78].”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

1 of the 85 references couldn’t be matched to a known paper.

Research works printed but not linked: 2

  1. McEntyre et al., 2015 Mouse -Less TMAO localization in tissues of diabetes mice Xu et al., 2009 Rat -Neutralizes endoplasmic reticulum stress via enhanced protein folding Lupachyk et al., 2013a; Lupachyk et al., 2013b continues Trimethylamine N-oxide (TMAO): Breathe new life British Journal of Pharmacology (2018) 175 1344-1353 1349 14765381, 2018, 8, Downloaded from https://bpspubs.onlinelibrary.wiley.com/doi/10.1111/bph.13959, Wiley Online Library on [30/08/2023]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License
  2. S Subramaniam and C Fletcher 1352 British Journal of Pharmacology (2018) 175 1344-1353 14765381, 2018, 8, Downloaded from https://bpspubs.onlinelibrary.wiley.com/doi/10.1111/bph.13959, Wiley Online Library on [30/08/2023]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License

Cited by

Sorted by citations

Authors
Subramaniam, S., & Fletcher, C.
Affiliations
University of North Carolina at Chapel Hill (US)
Corresponding author
  • Subramaniam, Saravanan
  • Fletcher, Craig
Venue
British Journal of Pharmacology
Publisher
Wiley
Published
2017-08-30
Volume
175
Issue
8
Pages
1344-1353
ISSN
  • 0007-1188 (ISSN-L)
  • 1476-5381
OpenAlex
W2784568242
Cited by
171
References
85
Citations by year
2026: 12 · 2025: 17 · 2024: 29 · 2023: 16 · 2022: 29 · 2021: 25 · 2020: 18 · 2019: 16 · 2018: 8 · 2017: 1
FWCI
1.10
Type
journal article
Language
en
Open access
Locations
  • British Journal of Pharmacology (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Polyamine Metabolism and Applications
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Metabolism and Genetic Disorders
Keywords
trimethylamine N-oxide, trimethylamine, cardiovascular disease, gut microbiota, choline metabolism, L-carnitine, FMO3, biomarkers, renal failure, thrombosis, atherosclerosis, obesity, diabetes mellitus, cancer, small molecules
MeSH terms
Animals, Brain Diseases, Heart Failure, Humans, Methylamines, Neoplasms, Obesity, Thrombosis

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review